<?xml version="1.0" encoding="UTF-8"?> <rss
version="2.0"
xmlns:content="http://purl.org/rss/1.0/modules/content/"
xmlns:wfw="http://wellformedweb.org/CommentAPI/"
xmlns:dc="http://purl.org/dc/elements/1.1/"
xmlns:atom="http://www.w3.org/2005/Atom"
xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
> <channel><title>Diabetes &#124; Type 2 Diabetes &#124; Diabetes Mellitus &#124; Keyvive.com &#187; JANUMET results in greater blood sugar reductions in patients with type 2 diabetes compared to pioglitazone</title> <atom:link href="http://www.keyvive.com/source/yahoo-com/janumet-results-in-greater-blood-sugar-reductions-in-patients-with-type-2-diabetes-compared-to-pioglitazone/feed/" rel="self" type="application/rss+xml" /><link>http://www.keyvive.com</link> <description>Healthy News on Diabetes</description> <lastBuildDate>Wed, 25 Jan 2012 20:52:07 +0000</lastBuildDate> <language>en</language> <sy:updatePeriod>hourly</sy:updatePeriod> <sy:updateFrequency>1</sy:updateFrequency> <generator>http://wordpress.org/?v=3.2.1</generator> <item><title>JANUMET results in greater blood sugar reductions in patients with type 2 diabetes compared to pioglitazone</title><link>http://www.keyvive.com/top-articles/diabetesblogs/yahoo-com/janumet-results-in-greater-blood-sugar-reductions-in-patients-with-type-2-diabetes-compared-to-pioglitazone/</link> <comments>http://www.keyvive.com/top-articles/diabetesblogs/yahoo-com/janumet-results-in-greater-blood-sugar-reductions-in-patients-with-type-2-diabetes-compared-to-pioglitazone/#comments</comments> <pubDate>Tue, 29 Jun 2010 01:00:00 +0000</pubDate> <dc:creator>type diabetes</dc:creator> <category><![CDATA[yahoo.com]]></category> <guid
isPermaLink="false">http://www.keyvive.com/?p=13640</guid> <description><![CDATA[<p>New data were presented at the American Diabetes Association 70th Annual Scientific Sessions from a study comparing JANUMET (sitagliptin/metformin) to pioglitazone. In this study, JANUMET resulted in significantly greater blood sugar reductions in patients with type 2 diabetes compared with pioglitazone.</p> ]]></description> <content:encoded><![CDATA[<p>New data were presented at the American Diabetes Association 70th Annual Scientific Sessions from a study comparing JANUMET (sitagliptin/metformin) to pioglitazone. In this study, JANUMET resulted in significantly greater blood sugar reductions in patients with type 2 diabetes compared with pioglitazone.</p> ]]></content:encoded> <wfw:commentRss>http://www.keyvive.com/top-articles/diabetesblogs/yahoo-com/janumet-results-in-greater-blood-sugar-reductions-in-patients-with-type-2-diabetes-compared-to-pioglitazone/feed/</wfw:commentRss> <slash:comments>0</slash:comments> </item> </channel> </rss>
